ID: ALA5273181

Max Phase: Preclinical

Molecular Formula: C20H14ClN5OS

Molecular Weight: 407.89

Associated Items:

Representations

Canonical SMILES:  O=C1CS/C(=N\c2cc(-c3c[nH]c4ccccc34)nn2-c2ccc(Cl)cc2)N1

Standard InChI:  InChI=1S/C20H14ClN5OS/c21-12-5-7-13(8-6-12)26-18(23-20-24-19(27)11-28-20)9-17(25-26)15-10-22-16-4-2-1-3-14(15)16/h1-10,22H,11H2,(H,23,24,27)

Standard InChI Key:  MEWSJFGNFMLAHD-UHFFFAOYSA-N

Associated Targets(Human)

BEAS-2B 690 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-MEL-28 48833 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16-F10 4610 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 407.89Molecular Weight (Monoisotopic): 407.0608AlogP: 4.52#Rotatable Bonds: 3
Polar Surface Area: 75.07Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.57CX Basic pKa: 0.94CX LogP: 4.69CX LogD: 4.47
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -1.17

References

1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N..  (2023)  Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors.,  14  (3): [PMID:36970141] [10.1039/d2md00442a]

Source